Company Analysis Divi`s Laboratories Limited
1. Summary
Advantages
- The stock's return over the last year (49.3%) is higher than the sector average (38.55%).
- The company's current efficiency (ROE=12.15%) is higher than the sector average (ROE=3.69%)
Disadvantages
- Price (5435.65 βΉ) is higher than fair price (717.22 βΉ)
- Dividends (0.6096%) are below the sector average (0.6496%).
- Current debt level 0.0211% has increased over 5 years from 0%.
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| Divi`s Laboratories Limited | Healthcare | Index | |
|---|---|---|---|
| 7 days | 0.6% | -3.5% | -2.9% |
| 90 days | 7.9% | -2.5% | -4.6% |
| 1 year | 49.3% | 38.6% | 8.7% |
DIVISLAB vs Sector: Divi`s Laboratories Limited has outperformed the "Healthcare" sector by 10.75% over the past year.
DIVISLAB vs Market: Divi`s Laboratories Limited has outperformed the market by 40.57% over the past year.
Stable price: DIVISLAB is not significantly more volatile than the rest of the market on "Bombay Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: DIVISLAB with weekly volatility of 0.9482% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (5435.65 βΉ) is higher than the fair price (717.22 βΉ).
Price is higher than fair: The current price (5435.65 βΉ) is 86.8% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (56.9) is higher than that of the sector as a whole (56.11).
P/E vs Market: The company's P/E (56.9) is higher than that of the market as a whole (43.66).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (6.71) is lower than that of the sector as a whole (8.08).
P/BV vs Market: The company's P/BV (6.71) is higher than that of the market as a whole (6.15).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (11.68) is lower than that of the sector as a whole (17.79).
P/S vs Market: The company's P/S indicator (11.68) is higher than that of the market as a whole (8.67).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (34.25) is higher than that of the sector as a whole (4.22).
EV/Ebitda vs Market: The company's EV/Ebitda (34.25) is higher than that of the market as a whole (15.13).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 3.25% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (3.25%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-17.15%).
5.4. ROE
ROE vs Sector: The company's ROE (12.15%) is higher than that of the sector as a whole (3.69%).
ROE vs Market: The company's ROE (12.15%) is higher than that of the market as a whole (-0.3088%).
5.5. ROA
ROA vs Sector: The company's ROA (10.7%) is higher than that of the sector as a whole (3.44%).
ROA vs Market: The company's ROA (10.7%) is higher than that of the market as a whole (7.53%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (11.26%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (16.2%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0.6096% is below the average for the sector '0.6496%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 0.6096% has been steadily paid over the past 7 years, DSI=0.93.
Weak dividend growth: The company's dividend yield 0.6096% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (49.75%) are at a comfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
